HOME     JOIN MAILING LIST     CONTACT US
 












The definitive medical forum in the Western Pacific Region on the care, prevention and treatment of diabetes.

Hosted by the Diabetic Society of Singapore, the 10th International Diabetes Federation-Western Pacific Region (IDF-WPR) Congress 2014 will be held from 21 to 24 November in Singapore.

Why you must attend this meeting:-

  1. Update yourself on knowledge of diabetes, learn new technological and pharmacological developments and better understand some of the controversies in diabetes care and management.
  2. Attend pre-congress workshops on Diabetes Education, Continuous Subcutaneous Insulin Infusion and the latest findings on Bariatric Surgery.
  3. Participate and discuss with basic scientists and researchers in the region and beyond on their seminal papers and studies in our extensive poster and oral presentation sessions.

 

News & Updates

8 Lunch Symposia happening from 22 – 23 November 2014

Spice up your lunch-time with our sponsored lunch symposia on 22 – 23 November, 12:30 – 14:00! Click on Day 1 and Day 2 tab on the programme to find out the titles of each sponsored lunch symposium.

Sponsored Symposia on Day 1
BI-Lilly Alliance  

Sponsored Symposia on Day 2

Exciting line-up for the 4 pre-congress workshops

  • Interested in knowing how to run an effective CGMS and insulin pump program?
  • What are the essentials of Bariatric and Metabolic surgery?
  • Want to learn more about the continuum of insulin therapy in type 2 diabetes through interactive case studies?
  • How to optimise diabetes management through the role of nutrition?

If you’re interested in the above, come join us at the pre-congress workshops happening on the 21 November! Click here for more information.


Key International Speakers

The Congress brings together distinguished speakers around the world with the aim to improve levels of clinical and basic research on diabetes in the region. These include:-

- Mobile connectivity and diabetes eHealth
- "Actionable" SMBG for patients using insulin
Emerging data about ARNT and other transcription factors in gene expression and islet dysfunction in type 2 diabetes and gestational diabetes
David Kerr, MD, FRCPE
Director of Research and Innovation
William Sansum Diabetes Center
Jenny Gunton
Chair of Medicine, University of Sydney, Westmead Hospital
President, Australian Diabetes Society
- The usefulness of glucose and lipid control in nephropathy and retinopathy
- Using HbA1c to diagnose diabetes is neither helpful, nor is it accurate
An Asian diabetes phenotype, or a phenotype in transition?

Juliana Chan
Chair Professor, Department of Medicine and Therapeutics
Director, Hong Kong Institute of Diabetes and Obesity
Co-director, IDF Centre of Education, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong
Jonathan Shaw
Associate Director
Health Services of Baker IDI Heart and Diabetes Institute
- The evolving paradigm in T2DM treatment with contemporary and complimentary therapeutic strategies
- DPP4 inhibitors: the CV outcomes trials
National diabetes care models: perspective from ASEAN countries
Lawrence A. Leiter, MD, FRCPC, FACP, FAHA
Professor of Medicine and Nutritional Sciences,
University of Toronto
Pongamorn Bunnag
Assistant Professor
Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine
Ramathibodi Hospital, Mahidol University
Type 1 diabetes mellitus in preschool children

Ragnar Hanas, MD, PhD
Associate Professor
The Sahlgrenska Academy
University of Gothenburg
Institute of Clinical Sciences
- Optimising glycemic control to protect renal and cardiovascular complications of type 2 diabetes- Findings from ADVANCE-ON
- National diabetes care models: perspective from ASEAN countries
Siew Pheng Chan, MBBS (Malaya), FRCP (Edinburgh), AM (Malaya)
Visiting Professor
Senior Consultant Endocrinologist
Endocrine Unit, Department of Medicine
University of Malaya Medical Centre, Kuala Lumpur, Malaysia
- Ethnic differences in genome-wide association studies
- Is diabetes truly still a coronary artery disease equivalent?
- The epigenome and its role in diabetes
- Adipose tissue inflammation and B regulatory cell dysfunction
Tai E Shyong
Senior consultant, National University Hospital
Associate Professor, Yong Loo Lin School of Medicine and Saw Swee Hock School of Public Health, National University of Singapore
Associate Professor, Duke-National University of Singapore Graduate Medical School
Takashi Kadowaki, MD, PhD
Professor of Diabetes and Metabolic Diseases
University of Tokyo
- Epidemic obesity and the rise of type 2 diabetes in Asia
- DPP-4 Inhibitors: Have We Optimized Their Role in the Treatment of Patients With Type 2 Diabetes?
Adiponectin, FGF21 and metabolic homeostasis
Yoon Kun-Ho
Professor of Department of Endocrinology and Metabolism,
Seoul St. Mary’s Hospital, The Catholic University of Korea
Xu Aimin, PhD, MD
Professor of Medicine,
Director of State Key Laboratory of Pharmaceutical Biotechnology,
The University of Hong Kong

Click here to view the scientific programme now!

 

 
All stated dates and timings for this conference are in accordance to the Singapore time, GMT +8.
Copyright © 2014 - 2015 IDF-WPR & AASD 2014

  Hosted by
Held in
 
 
Supported by
            
Chapter of Endocrinologists
College of Physicians, Singapore